RelA-Mediated BECN1 Expression Is Required for Reactive Oxygen Species-Induced Autophagy in Oral Cancer Cells Exposed to Low-Power Laser Irradiation

Low-power laser irradiation (LPLI) is a non-invasive and safe method for cancer treatment that alters a variety of physiological processes in the cells. Autophagy can play either a cytoprotective role or a detrimental role in cancer cells exposed to stress. The detailed mechanisms of autophagy and i...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 11; no. 9; p. e0160586
Main Authors Shu, Chih-Wen, Chang, Hong-Tai, Wu, Chieh-Shan, Chen, Chien-Hsun, Wu, Sam, Chang, Hsueh-Wei, Kuo, Soong-Yu, Fu, Earl, Liu, Pei-Feng, Hsieh, Yao-Dung
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 15.09.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Low-power laser irradiation (LPLI) is a non-invasive and safe method for cancer treatment that alters a variety of physiological processes in the cells. Autophagy can play either a cytoprotective role or a detrimental role in cancer cells exposed to stress. The detailed mechanisms of autophagy and its role on cytotoxicity in oral cancer cells exposed to LPLI remain unclear. In this study, we showed that LPLI at 810 nm with energy density 60 J/cm2 increased the number of microtubule associated protein 1 light chain 3 (MAP1LC3) puncta and increased autophagic flux in oral cancer cells. Moreover, reactive oxygen species (ROS) production was induced, which increased RelA transcriptional activity and beclin 1 (BECN1) expression in oral cancer cells irradiated with LPLI. Furthermore, ROS scavenger or knockdown of RelA diminished LPLI-induced BECN1 expression and MAP1LC3-II conversion. In addition, pharmacological and genetic ablation of autophagy significantly enhanced the effects of LPLI-induced apoptosis in oral cancer cells. These results suggest that autophagy may be a resistant mechanism for LPLI-induced apoptosis in oral cancer cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: Co-author Sam Wu is employed by Samwell Testing INC. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Conceptualization: CWS HTC YDH. Data curation: CWS PFL YDH. Formal analysis: SW HWC. Funding acquisition: CWS YDH. Investigation: CWS PFL YDH. Methodology: PFL CHC CWS. Project administration: CWS YDH. Resources: CSW SYK EF. Software: SW HWC. Supervision: CWS PFL YDH. Validation: CWS PFL YDH. Writing – original draft: CWS HTC PFL. Writing – review & editing: CWS HTC PFL.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0160586